PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF THE BISPECIFIC T-CELL ENGAGER ANTIBODY BLINATUMOMAB IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA

被引:0
|
作者
Hijazi, Y. [1 ]
Klinger, M. [1 ]
Schub, A. [1 ]
Wu, B. [2 ]
Zhu, M. [2 ]
Kufer, P. [1 ]
Wolf, A. [1 ]
Nagors-en, D. [3 ]
机构
[1] Amgen Res Munich GmbH, Munich, Germany
[2] Pharmacokinet & Drug Metab, Thousand Oaks, CA USA
[3] Amgen Inc, Clin Dev, Thousand Oaks, CA 91320 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P306
引用
收藏
页码:131 / 131
页数:1
相关论文
共 50 条
  • [41] Pulmonary T-Cell Non-Hodgkin's Lymphoma: Case report and review
    Mirza, Nureain
    White, Peter
    Henkle, Joseph
    CHEST, 2007, 132 (04) : 714S - 714S
  • [42] Non-Hodgkin's Anaplastic Large T-Cell Lymphoma: A Case Report
    Halpern, Gabriele A.
    Brochi, Luiza Miziara
    Gomes, Cintia
    Zusman, Gabriela Lachter
    de Macedo, Fabiane Carvalho
    Rodrigues, Juliana Annete Damasceno
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [43] Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts
    Dyer, MJS
    Siebert, R
    LEUKEMIA, 2006, 20 (02) : 208 - 209
  • [44] Soluble Fas in the serum of patients with non-Hodgkin's lymphoma: Higher concentrations in angioimmunoblastic T-cell lymphoma
    Yufu, Y
    Choi, I
    Hirase, N
    Tokoro, A
    Noguchi, Y
    Goto, T
    Uike, N
    Kozuru, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (04) : 334 - 336
  • [45] Spontaneous regression in mature T-cell non-Hodgkin lymphoma
    Ohmoto, Akihiro
    Fuji, Shigeo
    EXPERT REVIEW OF HEMATOLOGY, 2025, 18 (01) : 47 - 55
  • [46] Therapeutic bispecific T-cell engager antibody targeting the transferrin receptor
    Fu, M.
    Guo, Z.
    Tang, H.
    Zhu, H.
    Shen, G.
    Lei, P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1768 - 1768
  • [47] Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
    Fu, Mingpeng
    He, Qi
    Guo, Zilong
    Zhou, Xiaoran
    Li, Heli
    Zhao, Liang
    Tang, Hongling
    Zhou, Xiaoqi
    Zhu, Huifen
    Shen, Guanxin
    He, Yong
    Lei, Ping
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [48] PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIPS OF COPANLISIB IN PATIENTS WITH NON-HODGKIN LYMPHOMA AND ADVANCED SOLID TUMORS.
    Morschhauser, F.
    Awada, A.
    Machiels, J-P.
    Salles, G. A.
    Rottey, S.
    Rule, S.
    Cunningham, D.
    Peyrade, F.
    Fruchart, C.
    Arkenau, H-T.
    Genvresse, I.
    Liu, L.
    Kneip, C.
    Pena, C.
    Grevel, J.
    Zhang, J.
    Cisternas, G.
    Reschke, S.
    Granvil, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S80 - S81
  • [49] Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma
    Kleppe, Maria
    Tousseyn, Thomas
    Geissinger, Eva
    Atak, Zeynep Kalender
    Aerts, Stein
    Rosenwald, Andreas
    Wlodarska, Iwona
    Cools, Jan
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (11): : 1723 - 1727
  • [50] Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
    Chang, Sun Hee
    Lee, Hye Ran
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015